GSK Announces Plan to Limit Out-of-Pocket Costs for Inhalers in the US
US lawmakers in January had criticized the top four inhalers manufacturers over high prices
London: British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung…
